Combining RAIT and immune-based therapies to overcome resistance in cancer? Combining RAIT and immune-based therapies to overcome resistance in cancer?

Abstract : Radiation therapy has long been considered as immunosuppressive; therefore its impact on the immune system and other aspects which could be involved in raising efficient antitumor immune responses has been neglected. However, the recent demonstration of the immunogenic properties of ionizing radiation is rapidly modifying the radiation oncology field, and it also opens new and promising perspectives for the development and improvement of radioimmunotherapy. In this chapter, we first review the immunogenic properties of irradiation before discussing available evidence of the benefits of radiation therapy and immunotherapy combinations in the context of lymphoma.
Document type :
Book sections
Complete list of metadatas

Cited literature [116 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02338494
Contributor : Elizabeth Bernardo <>
Submitted on : Wednesday, October 30, 2019 - 8:48:17 AM
Last modification on : Wednesday, November 6, 2019 - 1:25:21 AM

File

GuillouxChapLivre2019Eq13.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Jean-Baptiste Gorin, Jérémie Ménager, Yannick Guilloux, Jean-François Chatal, Joëlle Gaschet, et al.. Combining RAIT and immune-based therapies to overcome resistance in cancer? Combining RAIT and immune-based therapies to overcome resistance in cancer?. Resistance to Ibritumomab in Lymphoma, 18, pp 119-137, 2018, ⟨10.1007/978-3-319-78238-6_9⟩. ⟨inserm-02338494⟩

Share

Metrics

Record views

11

Files downloads

11